January, 2017 - Dilon Technologies

Physician Insight for Patients: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting all the Cancer in the First Lumpectomy Surgery

By DAY Vision | January 30, 2017

Dr. Falk and his partner recently completed an evaluation comparing 120 cases using MarginProbe to 120 cases prior to that using the new technology.

Physician Insight for Patients: Dr. Vincent Reid – MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers

By DAY Vision | January 30, 2017

MarginProbe® Gives Patients the Best Chance for Only One Lumpectomy Procedure for Both Invasive and DCIS Breast Cancers

Physician Insight for Patients: Dr. Melanie Friedlander – MarginProbe® Greatly Enhances Outcomes with DCIS Breast Cancer Surgery

By DAY Vision | January 27, 2017

Dr. Melanie Friedlander, South Bay Surgeons: Specializes in General Surgery, Breast Surgery, Advanced Laparoscopic Surgery, Thyroid and Parathyroid surgery.

Archive for January 2017

Physician Insight for Patients: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting all the Cancer in the First Lumpectomy Surgery

Physician Insight for Patients: Dr. Vincent Reid – MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers

Physician Insight for Patients: Dr. Melanie Friedlander – MarginProbe® Greatly Enhances Outcomes with DCIS Breast Cancer Surgery

Products

Company